Results 41 to 50 of about 53,359 (237)

Advances in the Radiological Evaluation of and Theranostics for Glioblastoma [PDF]

, 2023
Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for ...
Hooper, Grayson W, Ansari, Shehbaz, Johnson, Jason M, Ginat, Daniel T   +3 more
core   +2 more sources

Mesenteric panniculitis presenting with acute non-occlusive colonic ischemia [PDF]

, 2011
Background The role of positron emission tomography (PET) of the mesentery as a diagnostic modality in cases of mesenteric panniculitis is unclear. Case presentation A 67-year-old woman presented with rectal bleeding due to nonocclusive colonic ischemia.
Amor, Florian, Farsad, Mohsen, Mazzoleni, Guido, Osele, Luzian, Pernter, Patrizia, Polato, Romano, Widmann, Josef, Wiedermann, Christian J   +7 more
core   +3 more sources

A New Method for 18FDG generating using Geant4/ Gate7

Basic & Clinical Cancer Research, 2023
Fluorine 18-deoxyglucose is often used in Positron Emission Tomography devices. Positron Emission Tomography imaging is one of the useful tools which is used for cancer detection and its management.
Abuzar Shakeri, Ebrahim Heidari, Seyedeh Nasrin Hosseini Motlagh, Hamid Reza Vanaei   +3 more
doaj  

Radiosynthesis, in vitro and preliminary biological evaluation of [F-18]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino) butanoic acid, a novel alanine serine cysteine transporter 2 inhibitor-based positron emission tomography tracer [PDF]

, 2020
The metabolic alterations in tumors make it possible to visualize the latter by means of positron emission tomography, enabling diagnosis and providing metabolic information.
Baguet, Tristan, Bouton, Jakob, De Vos, Filip, Descamps, Benedicte, Janssens, Jonas, Pauwelyn, Glenn, Van Calenbergh, Serge, Vanhove, Christian, Verhoeven, Jeroen   +8 more
core   +2 more sources

Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination

EJNMMI Radiopharmacy and Chemistry, 2022
Background Positron emission tomography (PET) is a powerful tool in medical imaging, especially in combination with the PET radionuclide fluorine-18 that possesses optimal characteristics.
Carsten Sven Kramer, Luca Greiner, Klaus Kopka, Martin Schäfer   +3 more
doaj   +1 more source

Synthesis, in vitro evaluation, and radiolabeling of fluorinated puromycin analogues: potential candidates for PET imaging of protein synthesis [PDF]

, 2016
There is currently no ideal radiotracer for imaging protein synthesis rate (PSR) by positron emission tomography (PET). Existing fluorine-18 labelled amino acid-based radiotracers predominantly visualize amino acid transporter processes, and in many ...
Alan C. Perkins, Carmen Tong, Franklin I. Aigbirhio, Helen M. Betts, Ishiwata K., Lampinen J., Philip J. Hill, Ramla O. Awais, Selena Milicevic Sephton   +8 more
core   +3 more sources

Strategies for radiolabelling antibody, antibody fragments and affibodies with fluorine-18 as tracers for positron emission tomography (PET) [PDF]

, 2017
The use of fluorine-18 as a radionuclide for positron emission tomography (PET) has become increasingly popular over the last two decades and cancer and neurology clinical centres worldwide are increasingly establishing competence in this modality for ...
Clark, Joshua, O'Hagan, David
core   +1 more source

Difference between carbohydrate antigen 19-9 and fluorine-18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual-center study [PDF]

, 2020
kita, H, Takahashi, H, Eguchi, H, et al. Difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline
Akita, Hirofumi, Asukai, Kei, Doki, Yuichiro, Eguchi, Hidetoshi, Gotoh, Kunihito, Hasegawa, Shinichiro, Iwagami, Yoshifumi, Kobayashi, Shogo, Noda, Takehiro, Sakon, Masato, Takahashi, Hidenori, Tomimaru, Yoshito, Wada, Hiroshi, Yamada, Daisaku   +13 more
core   +1 more source

Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals-radiosynthesis and ex vivo biodistribution of [18F] 3-(4-(2-(2-(2-fluoroethoxy) ethoxy) ethylthio)-1, 2, 5-thiadiazol-3-yl)-1-methyl-1, 2, 5, 6-tetrahydropyridine [PDF]

, 2010
Muscarinic receptors have been implicated in neurological disorders including Alzheimer’s disease, Parkinson’s disease, and schizophrenia. Nineteen derivatives of thiadiazolyltetrahydropyridine (TZTP), a core that has previously shown high affinities ...
Houle, Sylvain, Mamo, David, Mulsant, Benoit H., Pollock, Bruce G., van Oosten, Erik M., Vasdev, Neil, Wilson, Alan A.   +6 more
core   +1 more source

Improved detection of molecular markers of atherosclerotic plaques using sub-millimeter PET imaging [PDF]

, 2020
Since atherosclerotic plaques are small and sparse, their non-invasive detection via PET imaging requires both highly specific radiotracers as well as imaging systems with high sensitivity and resolution.
Bormans, Guy, Bridoux, Jessica, Broisat, Alexis, Caveliers, Vicky, Cleeren, Frederik, Debie, Pieterjan, Descamps, Benedicte, Devoogdt, Nick, Hernot, Sophie, Neyt, Sara, Vanhove, Christian, Xavier, Catarina   +11 more
core   +2 more sources